From a molecular compounding perspective, this medication represents a unique case, primarily due to its function. The primary compound, naproxen, demonstrates a complex interplay with prostaglandin production, specifically blocking cyclooxygenase-2 (COX-2) catalysts. This selective inhibition tries to lessen inflammation and pain while possibly mi